Alpha Tau Medical Ltd. (DRTS)
NASDAQ: DRTS · Real-Time Price · USD
8.09
+0.11 (1.38%)
Apr 24, 2026, 4:00 PM EDT - Market closed
Alpha Tau Medical Employees
Alpha Tau Medical had 121 employees as of December 31, 2025. The number of employees decreased by 4 or -3.20% compared to the previous year.
Employees
121
Change (1Y)
-4
Growth (1Y)
-3.20%
Revenue / Employee
n/a
Profits / Employee
-$352,289
Market Cap
712.00M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 121 | -4 | -3.20% |
| Dec 31, 2024 | 125 | 4 | 3.31% |
| Dec 31, 2023 | 121 | 27 | 28.72% |
| Dec 31, 2022 | 94 | 11 | 13.25% |
| Dec 31, 2021 | 83 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Gyre Therapeutics | 625 |
| Arvinas | 246 |
| Prime Medicine | 146 |
| Solid Biosciences | 121 |
| BridgeBio Oncology Therapeutics | 92 |
| Lexicon Pharmaceuticals | 81 |
| Vor Biopharma | 76 |
| Design Therapeutics | 54 |
DRTS News
- 2 days ago - Alpha Tau Announces FDA Approval of IDE Supplement to Expand Alpha DaRT® IMPACT Trial to Patients with Pancreatic Cancer Receiving Gemcitabine with Abraxane® (Nab-Paclitaxel) - GlobeNewsWire
- 2 days ago - Alpha Tau Successfully Treats First Pancreatic Cancer Patient in Europe with Alpha DaRT® in French Multicenter ACAPELLA Clinical Trial - GlobeNewsWire
- 25 days ago - Alpha Tau Announces First-Ever Oral Presentation of Alpha DaRT® Pancreatic Cancer Data at Digestive Disease Week (DDW) 2026 - GlobeNewsWire
- 5 weeks ago - Alpha Tau Medical Transcript: Sidoti March Small-Cap Virtual Conference - Transcripts
- 5 weeks ago - Alpha Tau to Present at Sidoti March Virtual Small Cap Conference - GlobeNewsWire
- 6 weeks ago - Alpha Tau Announces Full Year 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 2 months ago - HekaBio and Alpha Tau Medical Obtain Approval in Japan for Solid Tumor Treatment Alpha DaRT - Business Wire
- 2 months ago - Alpha Tau Medical Receives Japanese Marketing Approval for Alpha DaRT® in Unresectable Locally Advanced or Locally Recurrent Head and Neck Cancer - GlobeNewsWire